Exact Mass: 341.109

Exact Mass Matches: 341.109

Found 67 metabolites which its exact mass value is equals to given mass value 341.109, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-Phenethylsulfanyl-5,6,7,8-tetrahydro-benzo[4,5]thieno[2,3-d]pyrimidin-4-ylamine

2-Phenethylsulfanyl-5,6,7,8-tetrahydro-benzo[4,5]thieno[2,3-d]pyrimidin-4-ylamine

C18H19N3S2 (341.102)


   

protodeoxyviolaceinic acid

protodeoxyviolaceinic acid

C21H15N3O2 (341.1164)


A pyrrolecarboxylic acid that is pyrrole-2-carboxylic acid which is substituted at position 3 and 5 by indol-3-yl groups.

   

(2,5-Dihydroxypyrrol-1-yl) 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate

(2,5-Dihydroxypyrrol-1-yl) 5-[(3as,4S,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-D]imidazol-4-yl]pentanoic acid

C14H19N3O5S (341.1045)


   

(2,5-Dioxopyrrolidin-1-yl) 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoate

(2,5-Dioxopyrrolidin-1-yl) 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-D]imidazol-4-yl)pentanoic acid

C14H19N3O5S (341.1045)


   

Nep-IN-2

2-({1-hydroxy-2-[(2-methylphenyl)methyl]-3-sulphanylpropylidene}amino)-4-(methylsulphanyl)butanoic acid

C16H23NO3S2 (341.1119)


   

7,8-Dimethoxy-1-(4-nitrophenyl)-3,5-dihydro-2,3-benzodiazepin-4-one

7,8-dimethoxy-1-(4-nitrophenyl)-4,5-dihydro-3H-2,3-benzodiazepin-4-one

C17H15N3O5 (341.1012)


   
   
   
   

hydracyanoside E

hydracyanoside E

C15H19NO8 (341.1111)


   

Trigonostemine E

Trigonostemine E

C21H15N3O2 (341.1164)


   

Trigonostemine F

Trigonostemine F

C21H15N3O2 (341.1164)


   

Trigonostemine A

Trigonostemine A

C21H15N3O2 (341.1164)


   
   
   

4-Demethyl-4-carboxy tolazamide

4-Demethyl-4-carboxy tolazamide

C14H19N3O5S (341.1045)


   

hydracyanoside A

hydracyanoside A

C15H19NO8 (341.1111)


   
   

bisindolylmaleimide v

n-methylbis(indol-3-yl)maleimide

C21H15N3O2 (341.1164)


Bisindolylmaleimide V is a cell-permeable negative control for protein kinase C inhibition studies with an IC50 value over 100 μM[1]. Bisindolylmaleimide V blocks the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo with an IC50 of 8 μM[2].

   
   
   

1,N6-Benzoquinone-deoxyadenosine

1,N6-Benzoquinone-deoxyadenosine

C16H15N5O4 (341.1124)


   
   
   
   
   
   

Diethylpropion(metabolite VIII-glucuronide)

Diethylpropion(metabolite VIII-glucuronide)

C15H19NO8 (341.1111)


   
   

Ro 31-6045

3,4-di-1H-indol-3-yl-1-methyl-1H-pyrrole-2,5-dione

C21H15N3O2 (341.1164)


Bisindolylmaleimide V is a cell-permeable negative control for protein kinase C inhibition studies with an IC50 value over 100 μM[1]. Bisindolylmaleimide V blocks the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo with an IC50 of 8 μM[2].

   

Biotin NHS

6aR-hexahydro-2-oxo-2,5-dioxo-1-pyrrolidinyl ester-1H-thieno[3aS,4-d]imidazole-4S-pentanoic acid

C14H19N3O5S (341.1045)


   

4-TRIMETHYLAMMONIUM-2,2,6,6-TETRAMETHYLPIPERIDINE-1-OXYL IODIDE

4-TRIMETHYLAMMONIUM-2,2,6,6-TETRAMETHYLPIPERIDINE-1-OXYL IODIDE

C12H26IN2O (341.109)


   

Benzenesulfonamide,N-ethyl-4-methyl-N-(5-phenyl-2-furanyl)-

Benzenesulfonamide,N-ethyl-4-methyl-N-(5-phenyl-2-furanyl)-

C19H19NO3S (341.1086)


   

3-amino-2-nitro-1-phenyl-9,10-dihydrophenanthrene-4-carbonitrile

3-amino-2-nitro-1-phenyl-9,10-dihydrophenanthrene-4-carbonitrile

C21H15N3O2 (341.1164)


   

methyl (2S,3S,4S,5R,6S)-6-(4-acetamidophenoxy)-3,4,5-trihydroxyoxane-2-carboxylate

methyl (2S,3S,4S,5R,6S)-6-(4-acetamidophenoxy)-3,4,5-trihydroxyoxane-2-carboxylate

C15H19NO8 (341.1111)


   

6-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-5-CHLORONICOTINIC ACID

6-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-5-CHLORONICOTINIC ACID

C15H20ClN3O4 (341.1142)


   

2,5-Dioxopyrrolidin-1-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate

2,5-Dioxopyrrolidin-1-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate

C14H19N3O5S (341.1045)


   

4-[1-(4-fluorophenyl)-2-nitroethyl]-5-methyl-2-phenyl-1H-pyrazol-3-one

4-[1-(4-fluorophenyl)-2-nitroethyl]-5-methyl-2-phenyl-1H-pyrazol-3-one

C18H16FN3O3 (341.1176)


   

3,5-Dimethyl-4-[(4-methylphenyl)sulfonyl-phenylmethyl]isoxazole

3,5-Dimethyl-4-[(4-methylphenyl)sulfonyl-phenylmethyl]isoxazole

C19H19NO3S (341.1086)


   

L-Cysteinylglycyl-L-tyrosine

L-Cysteinylglycyl-L-tyrosine

C14H19N3O5S (341.1045)


   

1-Hydroxy-2,2,5,5-tetramethyl-3-(methylsulfonylsulfanylmethyl)-4-phenylpyrrole

1-Hydroxy-2,2,5,5-tetramethyl-3-(methylsulfonylsulfanylmethyl)-4-phenylpyrrole

C16H23NO3S2 (341.1119)


   

(2E)-3-{4-hydroxy-3-[(E)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-5-methoxyphenyl}prop-2-enoate

(2E)-3-{4-hydroxy-3-[(E)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-5-methoxyphenyl}prop-2-enoate

C19H17O6- (341.1025)


   

N-(6-Aminohexyl)-1-chloro-naphthalene-5-sulfonamide

N-(6-Aminohexyl)-1-chloro-naphthalene-5-sulfonamide

C16H22ClN2O2S+ (341.109)


   

N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide

N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide

C19H19NO3S (341.1086)


   

(2R)-atrovenetin

(2R)-atrovenetin

C19H17O6- (341.1025)


   

2,4,7,9-tetrahydroxy-6-methyl-8-(2-methylbut-3-en-2-yl)-1-oxo-1H-phenalen-3-ol

2,4,7,9-tetrahydroxy-6-methyl-8-(2-methylbut-3-en-2-yl)-1-oxo-1H-phenalen-3-ol

C19H17O6- (341.1025)


   
   
   

(4-Fluorophenyl)-[1-(4-thieno[2,3-d]pyrimidinyl)-4-piperidinyl]methanone

(4-Fluorophenyl)-[1-(4-thieno[2,3-d]pyrimidinyl)-4-piperidinyl]methanone

C18H16FN3OS (341.0998)


   
   
   
   

5-(1,4-Diazepan-1-ylsulfonyl)-4-(difluoromethyl)isoquinoline

5-(1,4-Diazepan-1-ylsulfonyl)-4-(difluoromethyl)isoquinoline

C15H17F2N3O2S (341.1009)


   

2,3,9-Trihydroxy-7-methyl-5-(2-methylbut-3-en-2-yl)-4,6-dioxophenalen-1-olate

2,3,9-Trihydroxy-7-methyl-5-(2-methylbut-3-en-2-yl)-4,6-dioxophenalen-1-olate

C19H17O6- (341.1025)


   

INDOLE-1-ACETIC ACID, 3-(p-FLUOROBENZOYL)-6-METHOXY-2-METHYL-

INDOLE-1-ACETIC ACID, 3-(p-FLUOROBENZOYL)-6-METHOXY-2-METHYL-

C19H16FNO4 (341.1063)


   

2-Phenethylsulfanyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-ylamine

2-Phenethylsulfanyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-ylamine

C18H19N3S2 (341.102)


   
   

1-(7-methoxyquinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol

1-(7-methoxyquinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol

C21H15N3O2 (341.1164)


   

2-(2-hydroxy-4-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile

2-(2-hydroxy-4-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile

C15H19NO8 (341.1111)


   

(2r)-2-(3-hydroxy-4-methoxyphenyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile

(2r)-2-(3-hydroxy-4-methoxyphenyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile

C15H19NO8 (341.1111)


   

2-(3-hydroxy-4-methoxyphenyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile

2-(3-hydroxy-4-methoxyphenyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}acetonitrile

C15H19NO8 (341.1111)


   

5-{[4-(2h-1,3-benzodioxol-5-ylmethyl)-1-methylimidazol-2-yl]imino}-2-hydroxy-3-methylimidazol-4-one

5-{[4-(2h-1,3-benzodioxol-5-ylmethyl)-1-methylimidazol-2-yl]imino}-2-hydroxy-3-methylimidazol-4-one

C16H15N5O4 (341.1124)


   

(3s,6z)-3-[2-hydroxy-2-(c-hydroxycarbonimidoylimino)ethyl]-6-(1h-indol-3-ylmethylidene)-3h-pyrazine-2,5-diol

(3s,6z)-3-[2-hydroxy-2-(c-hydroxycarbonimidoylimino)ethyl]-6-(1h-indol-3-ylmethylidene)-3h-pyrazine-2,5-diol

C16H15N5O4 (341.1124)


   

3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole

3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole

C21H15N3O2 (341.1164)


   

2-(2-hydroxy-4-methoxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile

2-(2-hydroxy-4-methoxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile

C15H19NO8 (341.1111)


   

7-methoxy-1-(quinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol

7-methoxy-1-(quinolin-4-yl)-9h-pyrido[3,4-b]indol-3-ol

C21H15N3O2 (341.1164)